Modulation of the pharmacokinetics of macromolecular contrast material by avidin chase: MRI, optical, and inductively coupled plasma mass spectrometry tracking of triply labeled albumin
Open Access
- 24 October 2003
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 50 (5), 904-914
- https://doi.org/10.1002/mrm.10638
Abstract
The goal of this work was to develop an MRI method for mapping the clearance of interstitial macromolecular plasma proteins after their extravasation from permeable blood vessels. To that end, a well-defined window of exposure to elevated blood levels was generated by inducing rapid clearance of macromolecular contrast material from the blood. Experimental removal of the intravascular component allowed subsequent tracking of clearance from the interstitial compartment in the absence of further contrast extravasation. The contrast material was based on albumin triply labeled with biotin, fluorescent tag, and GdDTPA, allowing optical, inductively coupled plasma mass spectrometry (ICP-MS) and MRI detection. The biotin tag was used here for in vivo chasing of the contrast material from the blood by intravenous administration of avidin. Upon administration of avidin the contrast material disappeared from the blood vessels and was cleared by the liver and spleen as detected by MRI, fluorescence of blood samples and histological sections, and by ICP-MS. Nonbiotinylated fluorescent albumin was not affected by administration of avidin. Contrast material that extravasated from leaky blood vessels in a VEGF overexpressing tumor, prior to administration of avidin, was not cleared by the addition of avidin and showed continued interstitial convection. Thus, avidin-chase provides an effective tool for in vivo manipulation of the arterial input function by providing experimental control over the rate of clearance of the contrast material from the circulation. Magn Reson Med 50:904–914, 2003.Keywords
This publication has 21 references indexed in Scilit:
- Pre-Targeted Locoregional Radioimmunotherapy with 90Y-biotin in Glioma Patients: Phase I Study and Preliminary Therapeutic ResultsCancer Biotherapy & Radiopharmaceuticals, 2001
- Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawalJournal of Clinical Investigation, 1999
- Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibodyNuclear Medicine and Biology, 1997
- Assessing tumor angiogenesis using macromolecular MR imaging contrast mediaJournal of Magnetic Resonance Imaging, 1997
- Inflammation-seeking scintigraphy with radiolabeled biotinylated polyclonal IgG followed by the injection of avidin chaseNuclear Medicine and Biology, 1996
- Liver Accumulation of TNP-modified Streptavidin and Avidin: Potential use for Targeted Radio- and ChemotherapyJournal of Drug Targeting, 1996
- Repeating the avidin “chase” markedly improved the biodistribution of radiolabelled biotinylated antibodies and promoted the excretion of additional background radioactivityEuropean Journal Of Cancer, 1995
- Comparison of the Chase Effects of Avidin, Streptavidin, Neutravidin, and Avidin‐Ferritin on a Radiolabeled Biotinylated Anti‐tumor Monoclonal AntibodyJapanese Journal of Cancer Research, 1995
- Tissue distribution of avidin and streptavidin injected to miceEuropean Journal of Biochemistry, 1990
- [2] Introduction to avidin-biotin technologyMethods in Enzymology, 1990